跳至主要内容
临床试验/JPRN-UMIN000030789
JPRN-UMIN000030789已完成未知

Effects of anti-allergic ophthalmic solutions on chemical mediators in tear fluid and on expression of chemical mediator receptors on conjunctival epithelial cells in patients with allergic conjunctivitis for pre-seasonal therapy - Effects of anti-allergic ophthalmic solutions on chemical mediators in tear fluid and on expression of chemical mediator receptors on conjunctival epithelial cells in patients with allergic conjunctivitis for pre-seasonal therapy

Santen Pharmaceutical Co., Ltd.0 个研究点目标入组 69 人开始时间: 2018年1月16日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
69

研究概览

简要总结

69 cases (Epinastine Intervention Group; 35 cases, Switch from Artificial Tears to Epinastine Intervention Group; 34 cases) were enrolled. As for both groups, expression levels of chemical mediator receptor mRNA on conjunctival epithelial cells were significantly increased at week 12 from the baseline (week 0). As for both groups, levels of chemical mediation in tears were not changed significantly. Through the study period, there were no side effects for both groups.

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patient under immunotherapy (including hyposensitization therapy and allassotherapy) Has history of allergy to the ingredients of the study drug and clinical reagents Patient who the investigator considers ineligible for enrolment

研究者

相似试验